ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) posted quarterly Gross Margin of 100.0% for Q1 2018, up 81.94% quarter-over-quarter from 54.96% in Q4 2017.

ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Gross Margin for 3 consecutive years, with 100.0% the latest figure, recorded in Q1 2018.

In Q1 2018, Gross Margin changed N/A year-over-year to 100.0%; the TTM figure through Dec 2018 stood at 100.0% (up 4914.0% YoY), while the FY2018 annual figure was 100.0%, up 4914.0% from the prior year.
Gross Margin improved to 100.0% in Q1 2018 per NDRA's latest filing, from 54.96% in the prior quarter.
Across five years, Gross Margin topped out at 100.0% in Q1 2018 and bottomed at 10.98% in Q2 2017.
Historically, Gross Margin has averaged 55.8% across 3 years, with a median of 54.96% in 2017.
On a YoY basis, Gross Margin climbed as much as 71 bps in 2017 and fell as far as 71 bps in 2017.
ENDRA Life Sciences' Gross Margin stood at 54.25% in 2016, then increased by 1 bps to 54.96% in 2017, then soared by 82 bps to 100.0% in 2018.
Business Quant data shows NDRA's Gross Margin at 100.0% in Q1 2018, 54.96% in Q4 2017, and 58.79% in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	69.57%
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	57.64%
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	64.58%
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	53.95%
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	32.85%
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	64.04%
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	66.44%
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	63.29%
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	29.80%
10	ENDRA Life Sciences	7.16 Mn	1.62 Mn	-	-

Download Data